Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BioChem Pharma and Adherex establish anticancer agreement

Aug. 25, 2000

AstraZeneca receives patent for new series of pyrimidine compounds

Aug. 24, 2000

PKC inhibitors under study at Kyowa Hakko

Aug. 24, 2000

Cancer researchers reveal extended activity of tyrosine kinase inhibitor

Aug. 24, 2000

Aronex's amended Atragen NDA accepted for FDA review

Aug. 23, 2000

Abbott describes novel selective MMP-2/MMP-9 inhibitors

Aug. 23, 2000

Kinase inhibitors demonstrate apoptotic activity in chronic lymphocytic leukemia

Aug. 23, 2000

Protein levels indicate severity of prostate cancer tumors

Aug. 23, 2000

NIH licensing opportunity: radiation therapy optimization technology

Aug. 23, 2000

Inex's Onco TCS given fast track status

Aug. 22, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...